The Sjögren's Syndrome Foundation testified before the U.S. House Ways and Means Oversight Subcommittee on Capitol Hill about the cost burden of over-the-counter (OTC) drugs and products patients depend on to treat Sjögren's.

The SSF was the only patient group represented at the hearing.

View the hearing and Steven Taylor, SSF CEO, testimony, which is shown around the 17 minute mark. 

http://waysandmeans.granicus.com/MediaPlayer.php?view_id=2&clip_id=279